𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytoreductive surgery prior to interleukin-2-based therapy in patients with metastatic renal cell carcinoma

✍ Scribed by McClellan M. Walther; Richard B. Alexander; Gary H. Weiss; David Venzon; Arlene Berman; Harvey I. Pass; W.Marston Linehan; Steven A. Rosenberg

Book ID
119047402
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
555 KB
Volume
42
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cytoreductive nephron-sparing surgery do
Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma
✍ Georg C. Hutterer; Jean-Jacques Patard; Marc Colombel; Arie S. Belldegrun; Chris πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 103 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. The role of nephron‐sparing surgery (NSS) showed promise in patients with metastatic renal cell carcinoma (MRCC). The disease‐specific survival of patients with MRCC was compared according to the type of surgery, NSS (N = 45) versus radical nephrectomy (RN) (N = 732), in